T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Goldman Sachs
GS
$304B
| $167M | 0.04% |
962,867
+6,560
| +0.7% | +$1.29M |
|
452
KBR
KBR
$4.81B
| $164M | 0.04% |
9,843,428
+89,828
| +0.9% | +$1.58M |
|
|
PX
453
DELISTED
Praxair Inc
PX
| $164M | 0.04% |
1,609,561
-464,369
| -22% | -$51.2M |
|
454
Masco
MAS
$14.7B
| $163M | 0.04% |
6,463,089
-6,890,953
| -52% | -$177M |
|
|
SEM
455
DELISTED
Select Medical
SEM
| $163M | 0.04% |
27,966,306
+1,828,234
| +7% | +$13.6M |
|
456
EastGroup Properties
EGP
$11B
| $162M | 0.04% |
2,996,259
+5,339
| +0.2% | +$301K |
|
457
Pacira BioSciences
PCRX
$924M
| $161M | 0.04% |
3,916,370
+50,543
| +1% | +$3.1M |
|
458
Western Digital
WDC
$168B
| $158M | 0.04% |
2,629,054
-2,533,094
| -49% | -$152M |
|
459
Southwest Gas
SWX
$6.67B
| $158M | 0.04% |
2,701,550
-17,020
| -0.6% | -$941K |
|
|
EIGI
460
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $158M | 0.04% |
11,791,174
+1,621,932
| +16% | +$27.9M |
|
461
Glacier Bancorp
GBCI
$6.48B
| $157M | 0.04% |
5,960,511
-305,070
| -5% | -$8.39M |
|
|
BLUE
462
DELISTED
bluebird bio
BLUE
| $157M | 0.03% |
141,305
+3,021
| +2% | +$5.51M |
|
463
Minerals Technologies
MTX
$2.26B
| $157M | 0.03% |
3,250,790
+1,032,433
| +47% | +$59.6M |
|
|
USG
464
DELISTED
Usg
USG
| $156M | 0.03% |
5,864,450
-239,600
| -4% | -$7.03M |
|
465
Stanley Black & Decker
SWK
$15.4B
| $156M | 0.03% |
1,606,063
-2,301,986
| -59% | -$237M |
|
466
Valero Energy
VLO
$98.7B
| $151M | 0.03% |
2,507,515
+1,544,842
| +160% | +$98.1M |
|
467
Novavax
NVAX
$1.34B
| $151M | 0.03% |
1,065,518
+72,195
| +7% | +$16.2M |
|
468
East-West Bancorp
EWBC
$18.6B
| $150M | 0.03% |
3,895,111
-540,610
| -12% | -$22.8M |
|
|
DNKN
469
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $149M | 0.03% |
3,042,300
+325,550
| +12% | +$16.9M |
|
|
CKH
470
DELISTED
Seacor Holdings Inc.
CKH
| $149M | 0.03% |
2,573,519
-15,297
| -0.6% | -$940K |
|
|
KKD
471
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $148M | 0.03% |
10,111,934
-106,720
| -1% | -$1.87M |
|
|
CSC
472
DELISTED
Computer Sciences
CSC
| $146M | 0.03% |
5,658,248
-338,888
| -6% | -$9.15M |
|
473
Scholastic
SCHL
$784M
| $146M | 0.03% |
3,736,282
-225,240
| -6% | -$9.69M |
|
474
Aon
AON
$75.7B
| $145M | 0.03% |
1,641,363
-255,600
| -13% | -$24.7M |
|
475
Middleby
MIDD
$5.29B
| $145M | 0.03% |
1,382,168
+69,203
| +5% | +$7.97M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.